BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3245748)

  • 1. Inhibition of hepatic microsomal carboxylesterase activity by paraoxon.
    Castle MC
    Arch Int Pharmacodyn Ther; 1988; 295():7-16. PubMed ID: 3245748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of hepatic carboxylesterase activity by soman: inhibition in vitro and enhancement in vivo.
    Castle MC
    Xenobiotica; 1989 Jan; 19(1):115-21. PubMed ID: 2756715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro deacetylation studies with isomeric acetamidobiphenyls using selective carboxylesterase inhibitors.
    Sertkaya NN; Gorrod JW
    Anticancer Res; 1988; 8(6):1345-50. PubMed ID: 3218967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isozyme-selective metabolism of ethyl carbamate by cytochrome P450 (CYP2E1) and carboxylesterase (hydrolase A) enzymes in murine liver microsomes.
    Lee RP; Parkinson A; Forkert PG
    Drug Metab Dispos; 1998 Jan; 26(1):60-5. PubMed ID: 9443854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial purification and characterization of a microsomal carboxylesterase specific for salicylate esters from guinea-pig liver.
    White KN; Hope DB
    Biochim Biophys Acta; 1984 Mar; 785(3):138-47. PubMed ID: 6704404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of hepatic microsomal esterase activity following soman pretreatment in guinea pigs.
    Luttrell WE; Castle MC
    Biochem Pharmacol; 1993 Dec; 46(11):2083-92. PubMed ID: 8267657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of procaine and ester hydrolysis by human, minipig, and rat skin and liver.
    Jewell C; Ackermann C; Payne NA; Fate G; Voorman R; Williams FM
    Drug Metab Dispos; 2007 Nov; 35(11):2015-22. PubMed ID: 17664252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major factors for the susceptibility of guinea pig to the pyrrolizidine alkaloid jacobine.
    Chung WG; Buhler DR
    Drug Metab Dispos; 1995 Nov; 23(11):1263-7. PubMed ID: 8591728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences in the hydrolysis of meperidine and its inhibition by organophosphate compounds.
    Luttrell WE; Castle MC
    Fundam Appl Toxicol; 1988 Aug; 11(2):323-32. PubMed ID: 3220210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hypophysectomy and pituitary hormones on hepatic microsomal carboxylesterase isozymes in male rats.
    Hosokawa M; Satoh T
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):279-88. PubMed ID: 3251337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine.
    Imai T; Taketani M; Shii M; Hosokawa M; Chiba K
    Drug Metab Dispos; 2006 Oct; 34(10):1734-41. PubMed ID: 16837570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between parathion and paraoxon toxicokinetics, lung metabolic activity, and cholinesterase inhibition in guinea pig and rabbit lungs.
    Lessire F; Gustin P; Delaunois A; Bloden S; Nemmar A; Vargas M; Ansay M
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):201-10. PubMed ID: 8658521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Debenzoylating and deacetylating activities of rat liver and mammary gland microsomes. Effect of ovariectomy.
    Ritter CL; Malejka-Giganti D
    Biochem Pharmacol; 1995 Oct; 50(8):1265-72. PubMed ID: 7488243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of ethyl carbamate by pulmonary cytochrome P450 and carboxylesterase isozymes: involvement of CYP2E1 and hydrolase A.
    Forkert PG; Lee RP
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):245-54. PubMed ID: 9344892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrolysis of ester- and amide-type drugs by the purified isoenzymes of nonspecific carboxylesterase from rat liver.
    Mentlein R; Heymann E
    Biochem Pharmacol; 1984 Apr; 33(8):1243-8. PubMed ID: 6712734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver.
    Sato Y; Miyashita A; Iwatsubo T; Usui T
    Drug Metab Dispos; 2012 May; 40(5):902-6. PubMed ID: 22293119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of activities and paraoxon sensitivities of hepatic aliesterases in beta-naphthoflavone-treated rats.
    Watson AM; Chambers H; Chambers JE
    Toxicol Lett; 1994 May; 71(3):217-25. PubMed ID: 8160210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration.
    Imai T; Yoshigae Y; Hosokawa M; Chiba K; Otagiri M
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1234-42. PubMed ID: 14534358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadal hormone-induced changes in hepatic microsomal carboxylesterase in rats.
    Hosokawa M; Satoh T; Ohkawara S; Ohmori S; Igarashi T; Ueno K; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):245-58. PubMed ID: 6515118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and pharmacological characterization of microsomal human liver flumazenil carboxylesterase.
    Kleingeist B; Böcker R; Geisslinger G; Brugger R
    J Pharm Pharm Sci; 1998; 1(1):38-46. PubMed ID: 10942971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.